The increasing incidence and prevalence of cancer, technological advancements in IHC, and the availability of reimbursement for IHC tests are the major factors driving the …
View Press-Release
The increasing incidence and prevalence of cancer, technological advancements in IHC, and the availability of reimbursement for IHC tests are the major factors driving the …
View Press-Release
The increasing incidence and prevalence of cancer, technological advancements in IHC, and the availability of reimbursement for IHC tests are the major factors driving the …
View Press-Release
According to the new market research report by MarketsandMarkets, the global immunohistochemistry market is projected to reach USD 2.7 billion by 2025 from USD 1.9 billion in …
View Press-Release